Morgan Stanley Maintains Overweight on SI-BONE, Raises Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Drew Ranieri maintains an Overweight rating on SI-BONE (NASDAQ:SIBN) and raises the price target from $27 to $30.
May 31, 2023 | 11:40 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley maintains an Overweight rating on SI-BONE and raises the price target from $27 to $30.
Morgan Stanley's decision to maintain an Overweight rating on SI-BONE and raise the price target from $27 to $30 indicates a positive outlook for the stock. This news is likely to have a positive impact on the stock price in the short term as it reflects the analyst's confidence in the company's performance and growth potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100